Phylogica chief scientific officer resigns
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Phylogica Ltd. said Robert Hayes stepped down as the company's chief scientific officer, effective Dec. 24.
The company does not plan to name a replacement for Hayes in the near future.
Hayes has been acting as the company's chief scientific officer since June 2017.
Perth, Australia-based Phylogica provides drug discovery research and development services.
